Dr Katrina Farrell
- Honorary Clinical Senior Lecturer (School of Medicine, Dentistry & Nursing)
email:
Katrina.Farrell@glasgow.ac.uk
Department of Haematology, Forth Valley Royal Hospital, Stirling Road, Larbert, FK5 4WR
Publications
2018
Ghesquières, H. et al. (2018) A susceptibility locus for classical Hodgkin lymphoma at 8q24 near MYC /PVT1 predicts patient outcome in two independent cohorts. British Journal of Haematology, 180(2), pp. 286-290. (doi: 10.1111/bjh.14306) (PMID:27716907) (PMCID:PMC5344766)
2016
Farrell, K., Fyfe, A., Allan, J., Tait, R. C. and Leach, M. (2016) An antithrombin replacement strategy during asparaginase therapy for acute lymphoblastic leukemia is associated with a reduction in thrombotic events. Leukemia and Lymphoma, 57(11), pp. 2568-2574. (doi: 10.3109/10428194.2016.1165815) (PMID:27078747)
2013
Forbes, A., Farrell, K., McKay, P., Bolam, S. and Rule, S. (2013) High dose cytarabine with rituximab is an effective first-line therapy for mantle cell lymphoma and produces ample stem cell harvest yields after multiple chemotherapy cycles. Leukemia and Lymphoma, 54(10), pp. 2303-2305. (doi: 10.3109/10428194.2013.769536)
2012
Farrell, K. and Rule, S. (2012) Mantle-cell lymphoma in the elderly: is it time to CHOP and change? Leukemia and Lymphoma, 53(10), pp. 1855-1856. (doi: 10.3109/10428194.2012.695361)
2011
Farrell, K., McKay, P. and Leach, M. (2011) Nodular lymphocyte predominant Hodgkin lymphoma behaves as a distinct clinical entity with good outcome: evidence from 14-year followup in the West of Scotland Cancer Network. Leukemia and Lymphoma, 52(10), pp. 1920-1928. (doi: 10.3109/10428194.2011.584993)
Farrell, K., Stobo, D. and Soutar, R. (2011) Cervical amyloidoma successfully treated with Bortezomib and Dexamethasone. Journal of Clinical Oncology, 29(17), e512-e513. (doi: 10.1200/JCO.2011.34.6452)
Farrell, K. and Jarrett, R.F. (2011) The molecular pathogenesis of Hodgkin lymphoma. Histopathology, 58(1), pp. 15-25. (doi: 10.1111/j.1365-2559.2010.03705.x)
Articles
Ghesquières, H. et al. (2018) A susceptibility locus for classical Hodgkin lymphoma at 8q24 near MYC /PVT1 predicts patient outcome in two independent cohorts. British Journal of Haematology, 180(2), pp. 286-290. (doi: 10.1111/bjh.14306) (PMID:27716907) (PMCID:PMC5344766)
Farrell, K., Fyfe, A., Allan, J., Tait, R. C. and Leach, M. (2016) An antithrombin replacement strategy during asparaginase therapy for acute lymphoblastic leukemia is associated with a reduction in thrombotic events. Leukemia and Lymphoma, 57(11), pp. 2568-2574. (doi: 10.3109/10428194.2016.1165815) (PMID:27078747)
Forbes, A., Farrell, K., McKay, P., Bolam, S. and Rule, S. (2013) High dose cytarabine with rituximab is an effective first-line therapy for mantle cell lymphoma and produces ample stem cell harvest yields after multiple chemotherapy cycles. Leukemia and Lymphoma, 54(10), pp. 2303-2305. (doi: 10.3109/10428194.2013.769536)
Farrell, K. and Rule, S. (2012) Mantle-cell lymphoma in the elderly: is it time to CHOP and change? Leukemia and Lymphoma, 53(10), pp. 1855-1856. (doi: 10.3109/10428194.2012.695361)
Farrell, K., McKay, P. and Leach, M. (2011) Nodular lymphocyte predominant Hodgkin lymphoma behaves as a distinct clinical entity with good outcome: evidence from 14-year followup in the West of Scotland Cancer Network. Leukemia and Lymphoma, 52(10), pp. 1920-1928. (doi: 10.3109/10428194.2011.584993)
Farrell, K., Stobo, D. and Soutar, R. (2011) Cervical amyloidoma successfully treated with Bortezomib and Dexamethasone. Journal of Clinical Oncology, 29(17), e512-e513. (doi: 10.1200/JCO.2011.34.6452)
Farrell, K. and Jarrett, R.F. (2011) The molecular pathogenesis of Hodgkin lymphoma. Histopathology, 58(1), pp. 15-25. (doi: 10.1111/j.1365-2559.2010.03705.x)